IMPORTANT ANNOUNCEMENT:

As public health safety concerns related to COVID-19 continue, the 2020 Pan Pacific Lymphoma Conference Directors and the UNMC Center for Continuing Education have made the tough decision to postpone the 2020 Pan Pacific Lymphoma Conference. We have rescheduled the conference for next year, August 9-13, 2021, and hope that you will be able to join us at the Fairmont Orchid, Hawaii then.

If you registered for the July 2020 event, YOU WILL RECEIVE A FULL REFUND IN THE SAME FORM OF PAYMENT THAT YOUR REGISTRATION WAS RECEIVED.

If you made hotel reservations at the Fairmont Orchid, Hawaii, please note that the hotel has canceled all Pan Pacific Lymphoma Conference participants' reservations.

Questions? Please contact Brenda Ram via email.

NEW DATE: August 9-13, 2021

More Than 20 Years of Educational Excellence

The Pan Pacific Lymphoma Conference is one of the largest gatherings of clinicians and researchers specializing in the areas of lymphoma and transplantation. The 2021 event is your chance to explore vital information on clinical updates and research, meet key thought leaders, and exchange ideas with more than 500 members of the multidisciplinary lymphoma clinical team including oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists.

Conference Venue

Fairmont Orchid 1 North Kaniku Drive Kohala Coast, HI 96743 Telephone: 1-808-885-2000 Make reservation for conference - coming soon! Go to hotel website

Conference Objectives

At the conclusion of the conference, the attendee should be better able to:

1. Evaluate results of clinical trials with current and emerging agents and regimens to develop evidence-based clinical management strategies in patients with Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL)
2. Formulate evidence-based management strategies for the optimal management of patients with lymphoma, leukemia, and myeloma, inclusive of multi-modality therapies and maintenance-based regimens
3. Analyze underlying molecular and cytogenetic abnormalities contributing to hematologic malignancies and their impact on diagnosis, prognosis, and therapeutic approaches
4. Evaluate the optimal patient selection, timing, and regimen for stem cell transplant and CAR-T cell therapy for patients with lymphoma
5. Personalize the treatment of hematologic malignancies based upon patient and disease-specific characteristics, and manage treatment-related adverse effects appropriately
6. Provide accurate and appropriate counsel as part of the treatment plan
7. Review factors that impact patient selection, availability, and enrollment into clinical trials, examining novel agents under investigation in patients with lymphoma, leukemia, and myeloma

Conference Directors

	James O. Armitage, MD Joe Shapiro Professor of Medicine Division of Oncology and Hematology Department of Internal Medicine University of Nebraska Medical Center
	Matthew A. Lunning, DO, FACP Associate Professor Division of Oncology and Hematology Department of Internal Medicine University of Nebraska Medical Center
	Robbe L. Peetz, MMS, PA-C Advanced Practice Provider Manager Cancer Services Nebraska Medicine
	Tawny J. Roeder, RN, BSN, BMTCN Case Manager, Blood and Marrow Transplantation Division of Oncology and Hematology Department of Internal Medicine Nebraska Medicine
	Julie M. Vose, MD, MBA Neumann M. and Mildred E. Harris Professor Chief, Division of Oncology and Hematology Department of Internal Medicine University of Nebraska Medical Center

Continuing Education Credits

Physicians

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 29.25 AMA PRA Category 1 Credits™. Each physician should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is provided for up to 29.25 contact hours under ANCC criteria.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider), University of Nebraska Medical Center, Center for Continuing Education (UNMC CCE), and the Postgraduate Institute for Medicine (PIM).

Pharmacists

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and UNMC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 29.25 contact hours (0.2925 CEUs) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

Sponsors

This conference is sponsored by the UNMC Department of Internal Medicine – Division of Oncology and Hematology, with the UNMC Center for Continuing Education, UNMC College of Nursing Continuing Nursing Education and Postgraduate Institute for Medicine.

For More Information

Contact Brenda Ram, CMP, CHCP via email or call 402-559-9250.